New approach seeks to spare rectal cancer patients from major surgery
NCT ID NCT06952101
Summary
This study is testing a personalized treatment plan for non-metastatic rectal cancer that aims to avoid removing the rectum when possible. For 200 patients, doctors will first use chemotherapy and radiation. If the tumor shrinks enough, patients may avoid major surgery and instead enter close monitoring or have a smaller, less invasive procedure. The goal is to control the cancer while preserving organ function and improving quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Department of Surgical Oncology - FPO-IRCCS Institute for Cancer Research and Treatment
RECRUITINGCandiolo, Turin, 10060, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.